Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 5:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 985–1008 of 6,918 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Fetal Alcohol Spectrum Disorders, Attention Deficit Hyperactivity Disorder
Interventions: Trigeminal Nerve Stimulation (TNS); Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 8 Years to 12 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Malignant Glioma
Interventions: CDX-110 with GM-CSF, Temozolomide; Drug
Lead sponsor: Celldex Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 34
States / cities: Orange, California • San Francisco, California • Stanford, California + 22 more

Conditions: Parkinson Disease
Interventions: Anodal tDCS, SHAM tDCS; Device
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 60 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Leukemia
Interventions: WT-1, Montanide, Sargramostim (GM-CSF); Biological · Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Bipolar Disorder
Interventions: Transcranial Phoobiomodulation (tPBM); Device
Lead sponsor: Paolo Cassano; Other
Eligibility: 18 Years to 65 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Schizophrenia
Interventions: Magstim Rapid 2 system triggering Magstim Super Rapid system; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Stroke, Rehabilitation, Hand
Interventions: transcranial direct current stimulation and electrical stimulator; Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 21 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cannabis Use Disorder
Interventions: transcranial alternating current stimulation, sham transcranial alternating current stimulation, Motivational interviewing (MI); Device · Behavioral
Lead sponsor: The Mind Research Network; Other
Eligibility: 21 Years to 65 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Intractable Neuropathic Pain, Pain, Back Pain, Lower Extremity Pain
Interventions: Precision for Spinal Cord Stimulation; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Belleville, Illinois

Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse
Interventions: DC/AML Fusion Vaccine, T-Cell Therapy, Decitabine, Venetoclax, GM-CSF; Biological · Drug
Lead sponsor: David Avigan; Other
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Non-Hodgkin's Lymphoma, Hodgkin's Disease, Multiple Myeloma, Other Plasma Cell Dyscrasia (Waldenstrom, Amyloidosis), Leukemia
Interventions: GM-CSF, IL-2; Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Primary Progressive Aphasia, MCI, FTD
Interventions: Active HD-tDCS plus Speech-Language Therapy, Sham plus Speech-Language Therapy; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 50 Years to 90 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Sarcopenia
Interventions: Muscle Tissue Biopsy, Maximal Oxygen Consumption (V02max); Procedure · Other
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 20 Years to 80 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Fanconi Anemia
Interventions: Anti-Thymocyte Globulin, Cyclophosphamide, Fludarabine, Hematopoietic Stem Cell Transplantation, Methylprednisolone, Filgrastim, Cyclosporine, Mycophenolate Mofetil; Biological · Drug · Procedure
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: Up to 59 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: MDS (Myelodysplastic Syndrome)
Interventions: INCB047986; Drug
Lead sponsor: Incyte Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 7
States / cities: Highland, California • Indianapolis, Indiana • Morristown, New Jersey + 4 more

Conditions: Long COVID, Chronic Fatigue Syndrome
Interventions: Transcutaneous Non-Invasive Vagus Nerve Stimulation; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: Up to 70 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Psychosis
Interventions: Active TMS, Placebo TMS; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 35 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Major Depressive Disorder
Interventions: Motif XCS System; Device
Lead sponsor: Motif Neurotech, Inc.; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 4
States / cities: Atlanta, Georgia • Iowa City, Iowa • Houston, Texas

Conditions: Neuroblastoma
Interventions: Carboplatin, Autologous stem cell infusion, Granulocyte colony stimulating factor, Radiation therapy, Isotretinoin (13-cis-retinoic acid), Melphalan, Etoposide; Drug · Biological · Radiation
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: Up to 30 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Nicotine Dependence
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 60 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Epilepsy
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Parkinson's Disease (PD)
Interventions: Summit RC+S; Device
Lead sponsor: Doris Wang, MD, PhD; Other
Eligibility: 21 Years to 75 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Metastatic Colorectal Cancer
Interventions: CY, GVAX, SGI-110; Drug · Biological
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Anemia
Interventions: methoxy polyethylene glycol-epoetin beta [Mircera]; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 6
States / cities: Los Angeles, California • San Jose, California • Boston, Massachusetts + 3 more

Search by objective public record fields.

Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure

Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme

Long- Term Transcranial Direct Current Stimulation in Parkinson's Disease

Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

Transcranial Photobiomodulation for Executive Function in Bipolar Disorder

Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Results

Improving Stroke Motor Control With Non-invasive Brain Stimulation and Functional Electrical Stimulation

Applying Neuromodulation to Boost the Efficacy of Motivational Interviewing

Spinal Cord Stimulation (SCS) for Neuropathic Pain of Back or Lower Extremity

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

tDCS Intervention in Primary Progressive Aphasia

Electrical Stimulation of Human Myocytes in Microgravity

Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia

Randomized Open-Label Study of INCB047986 in Subjects With Primary Myelodysplastic Syndrome (MDS)

Vagus Nerve Stimulation as Treatment for Long Covid

Psychosis TMS Study

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

High Dose Chemotherapy and Autologous Transplant for Neuroblastoma

NeuroControl of Nicotine Dependence

Study of Direct Brain Recording and Stimulation for Memory Enhancement

Movement State-dependent Adaptive DBS for PD

SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)

A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.